Label Promotion of Drugs and Medical Devices 2018
This session sets the context for the off-label promotion of medical products starting with early history and moving to the most recent history of FDA's decision on guidance documents. Why should you Attend: This session will discuss comments from industry, health care providers, health care insurers and other concerned parties. The latest legal considerations, decisions […]